ANI Pharmaceuticals Inc (ANIP)
54.16
-0.05
(-0.09%)
USD |
NASDAQ |
Dec 24, 16:00
ANI Pharmaceuticals Shareholders Equity (Quarterly): 430.80M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Windtree Therapeutics Inc | 4.409M |
| Allogene Therapeutics Inc | 463.75M |
| AIM ImmunoTech Inc | 2.912M |
| Protalix BioTherapeutics Inc | 32.44M |
| Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.287B |
| Total Liabilities (Quarterly) | 856.58M |
| Debt to Equity Ratio | 1.452 |
| Current Ratio | 2.745 |
| Net Debt Paydown Yield | -5.40% |